SCHEMBL7386629

SCHEMBL7386629

CCCOc1ccc(C(/N=C2\CCCCCCCCCCCN2)C2CCCC2)c(OCCC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
PSEN1 P49768 6/20 0.35
PSEN2 P49810 6/20 0.35
APH1B Q8WW43 6/20 0.35
NCSTN Q92542 6/20 0.35
APH1A Q96BI3 6/20 0.35
PSENEN Q9NZ42 6/20 0.35
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7334296 1.00 CYP1A2 (0.36) CYP1A2CYP2D6CYP2C19PSEN1PSEN2
SCHEMBL7334291 1.00 CYP1A2 (0.36) CYP1A2CYP2D6CYP2C19PSEN1PSEN2
SCHEMBL7328244 0.77 ALDH1A1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7328246 0.77 ALDH1A1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9719268 0.72 MEN1 (0.31) ALDH1A1
SCHEMBL9719264 0.72 MEN1 (0.31) ALDH1A1
SCHEMBL9719261 0.72 MEN1 (0.31) ALDH1A1
SCHEMBL11743620 0.69 ALOX12 (0.32)
SCHEMBL11743615 0.69 ALOX12 (0.32)
SCHEMBL7333402 0.68 IDO1 (0.39) GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5158945-A Cardiotonic agents, vasodilators, hypotensive agents, anticonvulsants, antiisichemic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-27 US disclosed
EP-0370320-B1 LACTAMIMIDES IN THE TREATMENT OF DRUG-RESISTANT PROTOZOAL INFECTIONS MERRELL DOW PHARMACEUTICALS INC. (US) 1992-09-30 EP disclosed